• Release Therapeutics SA

    GE
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-660.2.780.005-1
    Sector: Research and development

    Age of the company

    19 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    400'881

    Employees

    PremiumPremium

    Active brands

    6

    Reports for Release Therapeutics SA

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Shareholder Information

    Find out which national and international companies the stock corporation you are interested in also holds shares in.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Release Therapeutics SA

    • Release Therapeutics SA is active in the industry «Research and development» and is currently active. The legal headquarters are in Genève.
    • Release Therapeutics SA has 4 persons entered in its management.
    • All past changes can be viewed and saved as a PDF under the section «Notifications». The last change in the commercial register was made on 28.03.2025.
    • The company Release Therapeutics SA is registered under the UID CHE-112.690.021.
    • There are currently 6 trademarks or applications for the company Release Therapeutics SA in the IPI database.
    • Companies with an identical address: ARB Biotech Sàrl, Association Genilem, Association Health Innovation and Investment Exchange.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    La recherche, le développement et la commercialisation de thérapies innovantes notamment dans les domaines du traitement de maladies génétiques et de la vaccination. Elle peut également effectuer toutes opérationscommerciales, financières ou industrielles se rapportant directement ou indirectement à son but.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Ypsom Partners Sàrl
    Genève 09.10.2024

    Would you like to adjust the auditors? Click here.

    Former auditor (2)
    Name City Since Until
    CCCG SA
    Genève 07.03.2014 08.10.2024
    Finova Genève SA
    Genève 27.12.2005 06.03.2014

    Other company names

    Source: SOGC

    Past and translated company names

    • MaxiVAX SA
    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Trademarks

    Source: Swissreg
    Trademark Registration date Status Number
    to the trademark 17.01.2024 active 14196/2023
    17.01.2024 active 14196/2023

    Newest SOGC notifications: Release Therapeutics SA

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250328/2025 - 28.03.2025
    Categories: Change in management

    Publication number: HR02-1006295087, Commercial Registry Office Geneva, (660)

    Release Therapeutics SA, à Genève, CHE-112.690.021 (FOSC du 09.10.2024, p. 0/1006150135). Pavletic Aranicki Ksenija n'est plus administratrice;
    ses pouvoirs sont radiés. Les pouvoirs de Mehrling Thomas Jörg sont radiés. Signature collective à deux a été conférée à Grogg Julien Nicolas, de Thunstetten, à Lutry, directeur.

    SOGC 241009/2024 - 09.10.2024
    Categories: Change of company purpose, Change of auditors

    Publication number: HR02-1006150135, Commercial Registry Office Geneva, (660)

    Release Therapeutics SA, à Genève, CHE-112.690.021 (FOSC du 18.06.2024, p. 0/1006060514).

    Nouveau but:
    la recherche, le développement et la commercialisation de thérapies innovantes notamment dans les domaines du traitement de maladies génétiques et de la vaccination. Elle peut également effectuer toutes opérationscommerciales, financières ou industrielles se rapportant directement ou indirectement à son but. Statuts modifiés le 16.09.2024. CCCG SA (CHE-103.217.714) n'est plus organe de révision.

    Nouvel organe de révision:
    Ypsom Partners Sàrl (CHE-418.713.722), à Genève.

    SOGC 240618/2024 - 18.06.2024
    Categories: Change in capital, Change in management

    Publication number: HR02-1006060514, Commercial Registry Office Geneva, (660)

    Release Therapeutics SA, à Genève, CHE-112.690.021 (FOSC du 29.04.2024, p. 0/1006020752). Augmentation ordinaire du capital-actions porté de CHF 664'098, 4 à CHF 1'036'041, 4 par l'émission de 3'719'430 actions de CHF 0.1, nominatives, libérées par compensation de créances à hauteur de CHF 1'859'715 et en espèces à hauteur de CHF 1'859'715.

    Capital-actions:
    CHF 1'036'041, 4, entièrement libéré, divisé en 10'360'414 actions de CHF 0.10, nominatives. Statuts modifiés le 13.05.2024. Zimmermann Sven n'est plus administrateur;
    ses pouvoirs sont radiés.

    Nouvel administrateur:
    Mach Nicolas, de Genève, à Collonge-Bellerive, avec signature collective à deux.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm